Editas: 3Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $15.2 million in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of 32 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share.
The genome editing company posted revenue of $14.5 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $6.6 million.
Editas shares have declined roughly 7 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $28.62, a climb of 24 percent in the last 12 months.